These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3051398)
1. An overview of clinical trials in oncology. Leventhal BG Semin Oncol; 1988 Oct; 15(5):414-22. PubMed ID: 3051398 [No Abstract] [Full Text] [Related]
2. International Clinical Trials in Radiation Oncology. Chemical modifiers. Bartelink H; Bleehen NM; Phillips TL Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481 [No Abstract] [Full Text] [Related]
3. Medical oncology in the 1990s. Braverman AS Lancet; 1991 Apr; 337(8746):901-2. PubMed ID: 1672980 [No Abstract] [Full Text] [Related]
4. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy. Carter WH Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084 [No Abstract] [Full Text] [Related]
5. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going? Booth CM; Tannock I J Clin Oncol; 2008 Jan; 26(1):6-8. PubMed ID: 18165630 [No Abstract] [Full Text] [Related]
6. International Clinical Trials in Radiation Oncology. Large field trials. Rubin P; Heilmann HP Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S65-76. PubMed ID: 3292484 [No Abstract] [Full Text] [Related]
8. [Clinical trials for bladder cancer in Germany]. Lehmann J; Böhle A Urologe A; 2005 Dec; 44(12):1435-8. PubMed ID: 16258754 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of randomized clinical trials in cancer. Buyse M Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848 [No Abstract] [Full Text] [Related]
10. Factorial designs for randomized clinical trials. Byar DP; Piantadosi S Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085 [No Abstract] [Full Text] [Related]
11. Physiologic evaluation in the elderly prior to treatment with chemotherapy. Hallek M Clin Adv Hematol Oncol; 2007 Aug; 5(8):620-1. PubMed ID: 17982402 [No Abstract] [Full Text] [Related]
12. Reanalysis of cancer drugs: old drugs, new tricks. Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099 [No Abstract] [Full Text] [Related]
13. Combinations go on trial. Delude C Cancer Discov; 2012 Jan; 2(1):8. PubMed ID: 22585151 [No Abstract] [Full Text] [Related]
17. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs]. Wang ZY Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774 [No Abstract] [Full Text] [Related]
19. Preemptive (neoadjuvant) chemotherapy: can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons? Raghavan D; Wallace M Semin Oncol; 1990 Oct; 17(5):613-8. PubMed ID: 2218574 [No Abstract] [Full Text] [Related]
20. Drug targeting in cancer therapy: the magic bullet, what next? Duncan R; Connors TA; Meada H J Drug Target; 1996; 3(5):317-9. PubMed ID: 8866651 [No Abstract] [Full Text] [Related] [Next] [New Search]